China Heart Pump Devices Market

ID: MRFR/HC/52758-HCR

200 Pages

Garvit Vyas

September 2025

China Heart Pump Devices Market Research Report: By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices), By Therapy (Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination Therapy (DT), Others) andBy End-User (Hospitals &amp; C...

China Heart Pump Devices Market Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

China Heart Pump Devices Market Summary

The China Heart Pump Devices market is projected to experience substantial growth from 51.5 million USD in 2024 to 465 million USD by 2035.

Key Market Trends & Highlights

China Heart Pump Devices Key Trends and Highlights

The market is expected to grow at a compound annual growth rate of 22.14 percent from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 465 million USD, indicating robust expansion.
In 2024, the market is valued at 51.5 million USD, reflecting the current demand for heart pump devices in China.
Growing adoption of advanced heart pump technologies due to increasing cardiovascular diseases is a major market driver.

China Heart Pump Devices Market

CAGR

22.14%

Market Size & Forecast

2024 Market Size	51.5 (USD Million)
2035 Market Size	465 (USD Million)
CAGR (2025-2035)	22.14%

Major Players

Medtronic, ReliantHeart, LivaNova, Cleveland Heart, Sorin Group, Edwards Lifesciences, Abiomed, Maquet, AtriCure, HeartWare, Terumo, B. Braun, Getinge, Jiangsu Jichun, Roche

China Heart Pump Devices Market Trends

The China heart pump devices market is experiencing significant growth driven by several key market drivers. An aging population and an increase in cardiovascular diseases have escalated the demand for advanced heart pump devices.

The Chinese government has implemented policies aimed at improving healthcare infrastructure and accessibility, which supports the integration of innovative medical technologies. Furthermore, collaborations between domestic manufacturers and international companies are fostering the development of state-of-the-art heart pump devices tailored to local needs.

Opportunities to be explored in this market include the expansion of telemedicine and remote monitoring solutions, which can enhance patient care and improve outcomes. The rise of minimally invasive procedures has opened new avenues for product development, allowing for less hospital time and quicker recovery for patients.

Additionally, a focus on personalized medicine in China aligns with advancements in heart pump technologies that can be customized based on the patient's specific condition, thus presenting a unique opportunity for growth in this sector.

Recent trends in the China heart pump devices market indicate a shift towards the adoption of innovative technologies such as artificial intelligence and machine learning for patient monitoring. More manufacturers are investing in research and development to produce devices that are more efficient and user-friendly, responding to the increasing demand for high-quality healthcare products.

There is an evident trend towards increased regulatory support from the Chinese government as they aim to facilitate faster approvals for new medical devices, which further encourages market competition and innovation.

Market Segment Insights

Heart Pump Devices Market Product Insights

The China Heart Pump Devices Market is witnessing significant growth and innovation, particularly in the product segment, which encompasses an extensive range of advanced medical devices. At the forefront of these products are Ventricular Assist Devices, which are crucial in providing mechanical support to patients with weakened hearts, thereby enhancing their quality of life.

Left Ventricular Assist Devices (LVADs) are particularly prominent in this space as they are widely used for patients suffering from advanced heart failure, making them a pivotal solution within the therapeutic landscape. In contrast, Right Ventricular Assist Devices (RVADs) have gained importance in addressing specific cardiac issues related to the right side of the heart, showcasing the diverse applications of heart pump technology.

Bi-Ventricular Assist Devices further illustrate the adaptability of this segment, as they provide support to both sides of the heart, making them suitable for patients with comprehensive heart dysfunction. The emergence of Percutaneous Ventricular Assist Devices marks a significant advancement, allowing minimally invasive options for patients, which aligns with global trends toward less invasive treatments.

Transcutaneous Ventricular Assist Devices are also gaining traction, enabling continuous heart support with reduced surgical risks, which is particularly vital in a large market like China, where increasing cases of cardiovascular diseases are reported.

Intra-aortic balloon Pumps remain a vital component of this market, providing temporary mechanical support during high-risk surgeries and severe heart failure episodes. The Total Artificial Heart represents the pinnacle of innovation in heart pump devices, offering a complete solution for patients with end-stage heart failure, thus creating a specialized niche with substantial growth potential.

Heart Pump Devices Market Device Type Insights

The Device Type segmentation within the China Heart Pump Devices Market is critical to understanding the landscape of this rapidly evolving industry. Among the various types, Implantable Heart Pump Devices play a vital role as they provide long-term circulatory support to patients with severe heart conditions, thereby enhancing quality of life and reducing mortality rates.

This type caters mainly to individuals experiencing heart failure, which is increasingly prevalent in China due to its aging population and rising incidences of cardiovascular diseases. Extracorporeal Heart Pump Devices, on the other hand, have gained significant traction in acute settings, particularly within surgical and critical care environments where immediate and temporary intervention is necessary.

These devices facilitate blood circulation during procedures, helping to manage patients through high-risk operations. As the demand for advanced cardiac care continues to grow, driven by both an aging demographic and increased health awareness, focusing on these device types presents considerable opportunities for manufacturers.

Additionally, the Chinese government’s support for healthcare infrastructure and cardiovascular health initiatives aims to enhance treatment capabilities, further stimulating the growth of both device categories within the market.

Heart Pump Devices Market Therapy Insights

The Therapy segment of the China Heart Pump Devices Market has emerged as a pivotal component in the management of advanced heart failure. This segment encompasses various approaches including Bridge-to-candidacy, Bridge-to-transplant, and Destination Therapy, as well as other treatment options tailored to patient needs.

Bridge-to-candidacy focuses on stabilizing patients awaiting suitable heart transplants, thereby playing a critical role in improving survival rates and quality of life for these individuals. Similarly, Bridge-to-transplant aims to support patients in the interim before receiving a transplant, ensuring effective management of their condition.

Destination Therapy, on the other hand, serves as a vital solution for patients who are not candidates for transplant, offering them long-term heart support and significantly enhancing their life expectancy. The importance of these therapies is underscored by the rising prevalence of heart disease in China, necessitating advancements in treatment solutions.

As the country’s healthcare infrastructure evolves, integrating innovative heart pump technologies will likely meet the growing demand for effective heart failure management, representing a significant opportunity for growth in this market segment.

Heart Pump Devices Market End-User Insights

The China Heart Pump Devices Market is segmented by End-User into various categories, including Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutes, and Others. Hospitals and Clinics play a pivotal role in the adoption of heart pump devices, being the primary settings for patient treatment and care, contributing significantly to the overall demand for such technologies.

Ambulatory Surgical Centers have emerged as important players, providing less invasive treatment options, thus catering to a growing preference for outpatient care, which aligns with China's healthcare reforms aimed at improving efficiency. Research Institutes are crucial for innovation, focusing on the development of advanced heart pump technologies and conducting clinical trials that influence market dynamics.

Other facilities also contribute to the market by offering specialized care and services, thereby enhancing the availability of heart pump devices across different healthcare settings. This segmentation reflects the diverse landscape of healthcare in China, where the government is investing in modernizing medical facilities and expanding access to cardiac care, promoting market growth in heart pump devices.

Get more detailed insights about China Heart Pump Devices Market

Request Free Sample

Key Players and Competitive Insights

The China Heart Pump Devices Market has been evolving rapidly, driven by an increasing prevalence of cardiovascular diseases alongside a growing aging population. The competitive landscape of this market is characterized by various companies vying for market share through innovative products and advanced technology.

Companies are focusing on enhancing their product offerings, catering to the specific needs of patients and healthcare providers in China. The competitive analysis also reveals that regulatory considerations and local partnerships play crucial roles in market penetration for international players, given China's unique healthcare structure.

Understanding the dynamics of competition is essential for stakeholders aiming to navigate this fast-changing market successfully. Medtronic stands as one of the most significant players within the China Heart Pump Devices Market, leveraging its extensive experience and innovative capabilities in cardiovascular solutions.

Known for its robust portfolio, Medtronic primarily focuses on developing heart pumps and related medical devices that cater to various patient needs. The company's strengths lie in its strong brand recognition and established distribution networks throughout China, allowing it to effectively reach healthcare institutions.

Additionally, Medtronic's commitment to research and development has positioned it well in introducing cutting-edge technologies, such as minimally invasive heart pump systems that meet the unique demands and preferences of the Chinese market. This positioning complements the broader trend of prioritizing patient-centric solutions in the cardiac healthcare space.

ReliantHeart operates with a strategic focus on advancing heart pump technologies tailored to the needs of the Chinese market. Their key products include innovative ventricular assist devices designed to support patients suffering from advanced heart failure.

ReliantHeart has made notable strides in establishing a market presence by forming alliances with local hospitals and healthcare providers, effectively navigating the complex landscape of the Chinese healthcare system. The company's strengths include its agile approach to product development, which allows for faster adaptation to market demands and patient requirements.

Furthermore, ReliantHeart has been involved in various collaborations and partnerships, enhancing its footprint in China. The company's focus on innovation and local engagement positions it to capitalize on the escalating demand for advanced heart pump devices, affirming its competitive stance in this pivotal market.

Key Companies in the China Heart Pump Devices Market market include

Industry Developments

The China Heart Pump Devices Market has seen notable developments recently, particularly in September 2023 when Medtronic expanded its presence by launching its innovative heart pump devices tailored to the local market. In August 2023, ReliantHeart announced a partnership with a Chinese medical institution to enhance the adoption of its assist technologies.

Additionally, Edwards Lifesciences revealed a strategic investment aimed at increasing its manufacturing capacity in China, targeting a projected growth in demand for advanced heart pump solutions. Over the past few years, key players such as LivaNova and Abiomed have focused on localizing their production to better serve the rapidly growing patient population suffering from heart disease in China.

The market has been positively impacted, reflecting growth projections that indicate a compound annual growth rate exceeding 10% through 2025, driven by an aging population and rising cardiovascular incident rates. In the domain of mergers and acquisitions, Cleveland Heart has officially confirmed its acquisition of a technology firm in China to broaden its product offerings, escalating from initial negotiations that began in mid-2023.

Market Segmentation

Heart Pump Devices Market Product Outlook

Ventricular Assist Devices
Left Ventricular Assist Devices
Right Ventricular Assist Devices
Bi- Ventricular Assist Devices
Percutaneous Ventricular Assist Devices
Transcutaneous Ventricular Assist Devices
Intra-Aortic Balloon Pumps
Total Artificial Heart

Heart Pump Devices Market Therapy Outlook

Bridge-to-candidacy (BTC)
Bridge-to-transplant (BTC)
Destination Therapy (DT)
Others

Heart Pump Devices Market End-User Outlook

Hospitals & Clinics
Ambulatory Surgical Centers
Research Institutes
Others

Heart Pump Devices Market Device Type Outlook

Implantable Heart Pump Devices
Extracorporeal Heart Pump Devices

Report Scope

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	51.53(USD Million)
MARKET SIZE 2024	55.5(USD Million)
MARKET SIZE 2035	465.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	21.318% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Medtronic, ReliantHeart, LivaNova, Cleveland Heart, Sorin Group, Edwards Lifesciences, Abiomed, Maquet, AtriCure, HeartWare, Terumo, B. Braun, Getinge, Jiangsu Jichun, Roche
SEGMENTS COVERED	Product, Device Type, Therapy, End-User
KEY MARKET OPPORTUNITIES	Growing aging population, Rising prevalence of cardiovascular diseases, Increasing demand for minimally invasive procedures, Technological advancements in device design, Expanding healthcare infrastructure and investment
KEY MARKET DYNAMICS	rising cardiovascular diseases, increasing geriatric population, advanced medical technologies, government healthcare initiatives, growing awareness and education
COUNTRIES COVERED	China

FAQs

What is the expected market size of the China Heart Pump Devices Market in 2024?

In 2024, the China Heart Pump Devices Market is expected to be valued at 55.5 million USD.

What will be the market valuation of the China Heart Pump Devices Market by 2035?

The market is projected to reach a value of 465.0 million USD by 2035.

What is the expected compound annual growth rate (CAGR) for the China Heart Pump Devices Market from 2025 to 2035?

The market is anticipated to grow at a CAGR of 21.318% from 2025 to 2035.

Which product segment is valued the highest in the China Heart Pump Devices Market in 2024?

The Left Ventricular Assist Devices segment is valued at 20.6 million USD in 2024.

What is the projected value of Ventricular Assist Devices in the China Heart Pump Devices Market by 2035?

Ventricular Assist Devices are expected to reach a value of 112.0 million USD by 2035.

Who are the key players in the China Heart Pump Devices Market?

Major players include Medtronic, ReliantHeart, LivaNova, and Edwards Lifesciences among others.

What is the expected market size for Right Ventricular Assist Devices in 2024?

Right Ventricular Assist Devices are valued at 7.5 million USD in 2024.

What value is projected for Bi-Ventricular Assist Devices in the China Heart Pump Devices Market by 2035?

By 2035, Bi-Ventricular Assist Devices are projected to be valued at 55.0 million USD.

What is the market size for Percutaneous Ventricular Assist Devices in 2024?

The market size for Percutaneous Ventricular Assist Devices is 8.0 million USD in 2024.

What are the growth drivers for the China Heart Pump Devices Market?

The growth is driven by increasing heart diseases and technological advancements in heart pump devices.

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027